Krka Banned From Selling Valsaden
Ljubljana, 15 January - Slovenian drug maker Krka received on Tuesday a temporary injunction from the Ljubljana District Court banning Krka from producing and selling the valsaden pills and all other valsartan-based drugs due to a possibility of patent infringement.
The rest of this news item is available to subscribers.
The news item consists of 643 characters (without spaces) or 120 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.